CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Dilip Buildcon shines on bagging EPC project in Gujarat

Apurva Joshi 0 2885 Article rating: 3.9

Dilip Buildcon Limited informed the bourses on Thursday that its joint venture with Hindustan Construction Company (DBL-HCC) has received a letter of acceptance (LOA) from Narmada Water Resources, Water Supply and Kalpasar Department (Water Resources) for an engineering, procurement and construction (EPC) project in the state of Gujarat.

DoT withdraws AGR dues demand notices on GAIL & Power Grid

Apurva Joshi 0 1081 Article rating: 4.3

Department of Telecommunications (DoT), Ministry of Communications and Government of India has withdrawn provisional demand notices issued on GAIL Limited and Power Grid Corporation of India Limited. The dues were related to adjusted gross revenue (AGR) imposed over the telecom revenues earned by these companies.

Vaishali Pharma launches Vitamin C supplements to boost immunity

Apurva Joshi 0 1238 Article rating: 3.4

Vaishali Pharma Limited has launched Vipravita C (Vitamin C supplements) for domestic as well as international market to boost immunity against various prevailing diseases. These supplements are available in different variants like Vitamin C chewable tablets, Vitamin C effervescent tablets and Vitamin C with zinc combo.

Alankit and IDP join hands to provide innovative identity solutions range

Apurva Joshi 0 2503 Article rating: 4.3

Alankit Limited and IDP have come together with an aim to provide innovative identity solutions range. Alankit will be launching smart card printing solutions range (SOLID series), which is first-of-its-kind in India for secure, smart and seamless access through ID-cards such as PAN, Aadhaar, Corporate ID cards, student ID cards etc.

Cipla partners with Roche to provide oncology drugs in India

Apurva Joshi 0 1575 Article rating: 5.0

Cipla Limited and Roche Products (India) Pvt Ltd have joined hands to provide better access and innovative medicines for patients in India. Through this partnership, Cipla will undertake the activities of marketing and distribution of Roche’s key trademark oncology drugs like Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova).

Igarashi Motors closes units temporarily due to lockdown in Chennai

Apurva Joshi 0 1855 Article rating: 3.2

According to the announcement made by Igarashi Motors India Limited, its manufacturing units and corporate office at Chennai will be closed from June 19, 2020 to June 30, 2020 as Government of Tamil Nadu has imposed a complete lockdown in Chennai and its adjoining districts in light of a sudden rise in COVID-19 cases in the state and especially in Chennai.

Best & worst PSU performers in 2020 so far

Apurva Joshi 0 1671 Article rating: 2.6

The PSU index which consists of 57 PSU companies dipped by 30.9 per cent to 4,803.13 as on June 11, 2020 from 6,955.57 as on December 31, 2019. Of the total 57 PSU companies included in the BSE PSU index, only four companies have managed to deliver positive returns to the shareholders as yet in this year whereas the remaining 53 companies’ stocks have tumbled significantly.

USFDA approves Biocon & Mylans Semglee

Apurva Joshi 0 968 Article rating: 5.0

United States Food and Drug Administration (USFDA) granted approval to Semglee, an insulin glargine injection co-developed by Biocon Limited and Mylan N.V, which will be in vial and pre-filled pen presentations form used to keep in check high blood sugar in adults with type 2 diabetes, and adult and pediatric patients with type 1 diabetes.

Subsidiary of Rites to set up three GW solar plants for Indian Railways

Apurva Joshi 0 1214 Article rating: 5.0

Subsidiary of Rites Limited, Railway Energy Management Company Limited (REMCL) won its largest mandate from Indian Railways for handling tendering, installation supervision and managing power supply from three GW solar power plants which will be set up on vacant Indian Railway land.

Tata Coffee manages impact of COVID-19 admirably

Apurva Joshi 0 2776 Article rating: 3.3

Tata Coffee Limited has announced that since the lockdown situation is now being relaxed, its operations have restarted at full capacity in their instant coffee plants in India as well as other locations, including at the plantations. The harvesting of coffee and pepper has been completed while the hulling of coffee is still in progress.

Chennai Petroleum proposes JV to Indian Oil for Cauvery refinery project

Apurva Joshi 0 2884 Article rating: 3.7

The Board of directors of Chennai Petroleum Corporation Limited (CPCL) has proposed the implementation of the 9 MMTPA Refinery Project at Cauvery Basin Refinery, Nagapattinam district, to the Board of Indian Oil Corporation Limited (IOCL). CPCL plans to do this through a joint venture, at an anticipated cost of Rs 28,983 crore.

Gilead signs pact with 5 companies for COVID-19 treatment

Apurva Joshi 0 817 Article rating: 3.3

Gilead Sciences Inc. has entered into a non-exclusive licensing agreement with four Indian companies namely Cipla Ltd, Hetero Labs Ltd, Jubilant Life Sciences and Mylan and one Pakistani firm Ferozsons Laboratories. The agreement is for manufacturing and distribution of the investigational medicine Remdesivir.

Glenmark Pharma begins phase 3 clinical trial on antiviral tablet

Apurva Joshi 0 2782 Article rating: 3.5

Glenmark Pharmaceuticals Limited has initiated phase 3 clinical trials in India on antiviral tablet-Favipiravir, for which it had received an approval from India’s drug regulator-DCGI in late April. Glenmark is the first company in India to initiate phase 3 clinical trials on Favipiravir for COVID-19 patients in India.

RSS
1234567

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR